Buprex (Cinitapride,Omeprazole)

Quick links

Choose a section

Quick links to important sections

Advertisements

Buprex (Cinitapride,Omeprazole)

Advertisements
Advertisements

Method of action: Antiulcer

Treatment option:

Advertisements

Overview of Buprex (Cinitapride,Omeprazole)

What is Buprex (Cinitapride,Omeprazole)?

Buprex is a fixed-dose combination medication containing two distinct active ingredients: Cinitapride and Omeprazole. It is primarily utilized in the management of gastrointestinal disorders where both acid-related issues and motility disturbances are present.

Components and Mechanisms of Action

The effectiveness of this combination relies on the synergistic action of its two primary components:

  • Cinitapride: This agent is classified as a prokinetic. It works by enhancing the movement of the gastrointestinal tract. Specifically, it acts as a selective 5-HT4 receptor agonist and a 5-HT2 receptor antagonist. This action stimulates the release of acetylcholine, which accelerates gastric emptying and improves the coordination of the digestive system.
  • Omeprazole: This ingredient belongs to the class of medications known as proton pump inhibitors (PPIs). It reduces the production of gastric acid by inhibiting the H+/K+ ATPase enzyme system located in the parietal cells of the stomach lining. By lowering acid levels, it helps protect the esophagus and stomach from acid-induced irritation.

Therapeutic Purpose

This combination is designed to address conditions such as gastroesophageal reflux disease (GERD) and functional dyspepsia. While Omeprazole focuses on reducing the acidity of the stomach contents, Cinitapride addresses the underlying motility issues—such as delayed gastric emptying—that often contribute to the reflux of those contents into the esophagus.

By targeting both the chemical (acid) and mechanical (motility) aspects of digestion, the medication aims to alleviate symptoms such as heartburn, acid regurgitation, and the sensation of fullness or bloating after meals.

Regulatory References

  1. Omeprazole
  2. PubChem
Advertisements

What side effects are possible with Buprex (Cinitapride,Omeprazole)?

Possible Side Effects and Safety Information

This medication combines Cinitapride (a prokinetic agent) and Omeprazole (a proton pump inhibitor). While generally well-tolerated, side effects can occur, often being mild and resolving without intervention.

Common Side Effects

Side effects reported with either Cinitapride or Omeprazole, which may occur with this combination, typically include:

  • Gastrointestinal: Headache, nausea, vomiting, abdominal pain, diarrhea, and gas (flatulence).
  • Central Nervous System: Drowsiness and dizziness.

Serious Side Effects and Warnings

Seek immediate medical attention if you experience signs of a severe allergic reaction (hives, difficulty breathing, swelling of the face, lips, tongue, or throat) or severe skin reactions (red, blistering, or peeling skin).

Omeprazole use, particularly with long-term therapy (over a year), is associated with a few potential risks:

Potential Long-Term Risk (Omeprazole) Associated Symptoms to Monitor
Low Magnesium Levels (Hypomagnesemia) Seizures, irregular or fast heartbeat, muscle spasms, tremors, or weakness.
Vitamin B12 Deficiency Numbness or tingling in the hands or feet, unusual weakness, or nervousness.
Increased Fracture Risk New or unusual bone pain in the hip, wrist, or spine.
Kidney Problems (Acute Interstitial Nephritis) Decreased urination, blood in the urine, or general fever and rash.
Severe Diarrhea (C. difficile-associated) Persistent, watery diarrhea, abdominal pain, and fever.

Inform your healthcare provider if you have a history of liver or kidney impairment, or conditions like lupus, as these may require cautious use and monitoring. Due to the potential for drowsiness, use caution when driving or operating machinery until you know how this medication affects you.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Buprex overdose centers on the documented manifestations and the explicit need for urgent action. Immediate medical help or contact with a Poison Control Center must be sought right away in the event of a suspected overdose.

Documented clinical manifestations primarily involve the central nervous system and motor functions. These signs may include drowsiness (somnolence) and confusion (disorientation). Overdosage may also result in extrapyramidal effects, which are officially described as involuntary muscular movements such as spasms of the head, neck, or tongue. Medical intervention is required if these documented symptoms persist.

The standard management of overdose is officially defined as symptomatic and supportive treatment. In cases of excessive overdosage, specific procedures such as gastric lavage and the application of symptomatic therapy are the described measures. It is noted that no specific antidote for the core drug substance is documented; however, extrapyramidal symptoms are controlled by administering specific agents, including antiparkinsonian, anticholinergic, or antihistaminic drugs. No specific population-based differences in overdose severity are detailed in the official regulatory documents.

Advertisements

Therapeutic Uses of Buprex (Cinitapride,Omeprazole)

Understanding Buprex (Cinitapride/Omeprazole)

Buprex is a fixed-dose combination medication containing two active ingredients: cinitapride and omeprazole. This combination is designed to address gastrointestinal disorders where both acid-related issues and motility disturbances occur simultaneously. By combining a prokinetic agent with a proton pump inhibitor (PPI), the medication provides a dual approach to managing upper digestive tract symptoms.

Main Therapeutic Uses

This medication is primarily used to manage conditions affecting the esophagus, stomach, and the initial part of the small intestine. Its applications include:

  • Gastroesophageal Reflux Disease (GERD): It is used when patients experience persistent heartburn or acid regurgitation that does not respond sufficiently to acid suppression alone.
  • Functional Dyspepsia: This refers to chronic or recurrent pain or discomfort centered in the upper abdomen. It is often used for the "dysmotility-like" subtype, characterized by early fullness, bloating, or nausea after eating.
  • Secondary Gastroparesis: It may be utilized to assist in stomach emptying when the movement of food from the stomach to the small intestine is delayed.

Mechanism of Action and Benefits

The efficacy of this combination lies in how the two components work together to restore digestive balance.

Acid Suppression (Omeprazole)

Omeprazole acts by inhibiting the proton pumps in the stomach lining. This significantly reduces the production of gastric acid. Lowering the acidity of the stomach contents helps to:

  • Protect the esophageal lining from acid damage.
  • Allow existing ulcers or erosions in the digestive tract to heal.
  • Alleviate the burning sensation associated with excess acid.

Motility Improvement (Cinitapride)

Cinitapride is a prokinetic agent that enhances the movement of the gastrointestinal tract. It works by stimulating specific receptors (5-HT4) and inhibiting others (5-HT2), which results in:

  • Increased tone of the lower esophageal sphincter, preventing acid from splashing upward.
  • Accelerated gastric emptying, which reduces the time food and acid stay in the stomach.
  • Improved coordination of the digestive muscles, reducing feelings of heaviness and bloating.

Combined Benefits for the Patient

By addressing both the chemistry (acid) and the mechanics (movement) of digestion, the combination therapy aims to provide more comprehensive symptom relief than either medication used in isolation. This is particularly beneficial for patients whose reflux is driven by a "lazy" stomach or poor esophageal clearance, as it tackles the root mechanical cause while simultaneously neutralizing the irritating acid.

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Buprex (Cinitapride,Omeprazole)?

Eligibility for Buprex is determined by regulatory rules concerning the population and specific health conditions, reflecting the combination of a Prokinetic Agent (Cinitapride) and a Proton Pump Inhibitor (Omeprazole).

Absolute Contraindications

Use is prohibited in patients with conditions where stimulating gut motility may be harmful, including known Gastrointestinal hemorrhage, mechanical obstruction, or perforation. It is also contraindicated in patients with a history of neuroleptic-induced tardive dyskinesia and those with a known hypersensitivity to either active ingredient or their respective chemical classes (benzamides/benzimidazoles). Concomitant use with specific antiviral medications, such as Nelfinavir or Rilpivirine, is also forbidden.

Population Restrictions and Cautions

Population Group Regulatory Status Restriction Basis
Children/Adolescents Not Recommended Lack of established safety/effectiveness data for the combination.
Pregnancy Restricted Contraindicated in the first trimester; overall use only if benefit justifies risk.
Lactation Not Recommended Both components may pass into breast milk.
Hepatic Impairment Caution Required Risk of increased Omeprazole exposure; dose adjustment may be necessary.
Older Adults Caution Required Due to the effects of the Cinitapride component on acetylcholine action.

Eligibility extends primarily to adult patients provided none of the documented contraindications or limitations apply.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes specific interaction patterns for both the Omeprazole and Cinitapride components.

Contraindicated and Restricted Combinations

Co-administration is formally contraindicated in the presence of active gastrointestinal hemorrhages, obstructions, or perforations due to the Cinitapride component. Use with Clopidogrel is not recommended in official prescribing information, as Omeprazole may diminish its anti-platelet activity. The concomitant use of Omeprazole with antiretrovirals like Atazanavir and Nelfinavir is also not recommended, as Omeprazole reduces their plasma concentrations.

Pharmacokinetic and Pharmacodynamic Effects

Interaction Type Interacting Substance Examples Official Outcome
Metabolic (CYP2C19 Inhibition) Diazepam, Warfarin, Phenytoin Increased exposure and prolonged elimination.
Absorption (Gastric pH) Ketoconazole, Iron Salts Decreased absorption and reduced effectiveness.
Pharmacodynamic (CNS) Alcohol, Hypnotics, Narcotics Enhanced sedative effects.

Omeprazole may also elevate the serum concentrations of agents such as Methotrexate and Tacrolimus. Additionally, the herbal product St. John's Wort is documented to potentially reduce Omeprazole concentrations, and avoidance is advised.

Advertisements

Mechanism of Action

Omeprazole, a substituted benzimidazole, functions as a proton pump inhibitor (PPI). It is a prodrug that selectively accumulates and is protonated in the highly acidic canaliculi of the gastric parietal cells. The protonated form subsequently undergoes a chemical rearrangement to generate a reactive sulfenamide intermediate. This active species forms a covalent, irreversible bond with specific cysteine residues on the H^+,K^+-ATPase enzyme, commonly known as the gastric acid pump. This molecular interaction leads to the suppression of the final step of basal and stimulated gastric acid secretion, irrespective of the initiating stimulus.

Cinitapride, a prokinetic agent, modulates gastrointestinal motility via a dual interaction with serotonin receptors in the enteric nervous system. It acts as a partial agonist at the 5-HT4 receptors and a competitive antagonist at the 5-HT2 receptors. The 5-HT4 agonism enhances the local release of acetylcholine, a neurotransmitter that stimulates smooth muscle contraction. Concurrently, the 5-HT2 antagonism counteracts the inhibitory effects of serotonin on motility. The resultant intracellular signaling cascade promotes coordinated smooth muscle contractions, leading to increased gastric and small intestinal propulsive movement and enhanced lower esophageal sphincter (LES) tone. The system-level physiological consequence of this dual mechanism is the modulation of the upper gastrointestinal transit rate.

Advertisements

Dosage and Administration Information

How to use Buprex (Cinitapride, Omeprazole)

The usage of Buprex, a fixed-dose oral capsule combining Cinitapride and Omeprazole, is defined by parameters concerning its route, dose, frequency, and administration conditions. These constraints establish the standardized approach to using the medicine.

Instruction Detail
Route of administration The medication is intended for oral administration only.
Dosing schedule The standard adult regimen specifies one capsule taken once daily. Each capsule contains the fixed strength of Omeprazole 20 mg and Cinitapride 3 mg.
Timing in relation to meals Dosing must occur before a meal to ensure appropriate physiological conditions for the Omeprazole component, and is typically recommended in the morning.
Administration Conditions The capsule must be swallowed whole with water and must not be chewed, opened, or crushed. This requirement is necessary to maintain the integrity of the delayed- and extended-release properties of the components.
Course duration The use is generally limited to a short-term course, often consistent with the 4 to 8 week regimens associated with the Omeprazole component for related conditions.
Age and Impairment Rules No specific dose adjustment is typically required for older adults or in renal impairment. However, the protocol includes monitoring for patients with severe hepatic impairment.

The administration protocol specifies that the fixed 20 mg/3 mg capsule strength is administered once daily according to a pre-meal schedule. This regimen also incorporates procedural constraints, such as swallowing the capsule whole, to ensure the two active components are delivered as intended. These standardized instructions define the conditions and the time frame for the use of the combination drug.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of studies for Buprex (Cinitapride, Omeprazole)

Research examining the fixed-dose combination of Cinitapride and Omeprazole has primarily focused on settings where symptoms are linked both to excessive gastric acid and to issues with how food moves through the upper digestive tract. Studies monitored symptomatic patterns over short periods in defined patient groups.


Research Evidence for Symptoms Related to Gastroesophageal Reflux Disease (GERD) with Motility Issues

Research exploring this combination has used short-term Randomized Controlled Trials (RCTs) in studies examining how symptoms change over time in adults with GERD. These studies specifically involved populations who had an inadequate response to prior monotherapy with a Proton Pump Inhibitor (PPI) alone. Research monitored key patient-reported outcomes describing perceived discomfort, such as the intensity of heartburn and frequency of regurgitation. Studies reported patterns observed in the studies related to acute symptomatic relief over short time intervals, generally four weeks or less.


Studies Investigating Functional Dyspepsia Symptoms

Studies have explored the use of the medicine’s components in individuals with functional dyspepsia, a condition marked by functional limitations. Research examined outcomes related to physical discomfort, monitoring changes in perceived symptoms like bloating and early satiety in the observed populations. In addition to symptom scoring, some studies monitored objective functional outcomes, such as measurements of the gastric emptying rate. A key limitation is that many high-quality trials focused only on the Cinitapride component independently or compared it to other similar agents, meaning comparative evidence for the fixed combination can be limited and heterogeneous.


Areas of Research Uncertainty and Study Gaps

Evidence highlights what is still uncertain about the combination. Key limitations include the fact that follow-up durations were limited across many published studies, meaning long-term effects are not fully established. Additionally, comparative evidence against existing standard treatments is often lacking. Data for certain groups, such as those with highly complex conditions or older populations, remain insufficient, and subgroup findings are uncertain.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Buprex (Cinitapride,Omeprazole) (FAQ)


Q: What is the difference between Buprex and just taking Omeprazole alone?

The primary difference is the inclusion of Cinitapride, a prokinetic agent, alongside Omeprazole. While Omeprazole suppresses stomach acid, Cinitapride enhances the movement and emptying of the stomach and small intestine. This fixed-dose combination provides a dual approach to managing digestive symptoms related to both acid and motility issues.


Q: Is Buprex considered a strong medication for acid reflux?

Regulatory classifications describe the Omeprazole component as a potent Proton Pump Inhibitor (PPI). PPIs are a major class of medicines used to reduce stomach acid, known for their potency. This ingredient is designed to provide prolonged suppression of gastric acid production.


Q: How quickly does Buprex start to work for heartburn?

The Omeprazole component starts reducing stomach acid within about one hour of ingestion. However, because the drug needs to build up its effect on the acid pumps, it may take several days of consistent, daily use to achieve the full therapeutic benefit. Official documents note that full symptom relief may take several days of consistent use.


Q: How long does the effect of one dose of Buprex typically last?

Official product information indicates that the acid-suppressing effect of Omeprazole can last for up to 36 hours. However, the maximum effect on acid reduction is generally achieved after several days of consistent, daily dosing. The core effect is prolonged acid suppression.


Q: Do I need to take Buprex forever once I start it?

No. This combination medicine is typically prescribed for a short and defined course to address specific symptoms, not for indefinite, lifelong use. A healthcare provider will determine the appropriate duration for the treatment based on the condition being addressed.


Q: Is Buprex suitable for long-term use, according to research?

Regulatory guidelines specify that this medicine is intended for a short and defined course, often between 4 and 8 weeks, for certain conditions. Long-term use of the Omeprazole component is associated with potential risks. The continued use beyond the established short-term duration is addressed by a healthcare provider.


Q: What happens if I miss a dose of Buprex?

According to patient information, if you realize you missed a dose, you may take it as soon as possible. However, if it is almost time for your next scheduled dose, skip the one you missed and continue with your regular schedule. Regulatory instructions state not to take a double dose to compensate for the missed one.


Q: Is it common to feel tired when first starting Buprex?

While the official list of common side effects includes drowsiness, tiredness and fatigue have also been reported in association with the Omeprazole component. If symptoms are persistent or concerning, a healthcare professional can provide guidance.


Q: Are there any food or drinks that interfere with Buprex?

The medicine must be taken at least one hour before a meal. Certain acidic, fatty, or spicy foods are commonly known to exacerbate reflux symptoms, and avoiding them may be helpful. Some evidence also suggests that substances found in grape juice may interact with the absorption of the Omeprazole component.


Q: Can Buprex be taken with common vitamins or mineral supplements?

Caution is necessary because the acid-reducing effect of Omeprazole can potentially interfere with the absorption of certain nutrients, most notably Magnesium and Vitamin B12. Information regarding all common vitamins and mineral supplements should be addressed with a healthcare provider.


Q: Is Buprex safe for older adults or seniors?

Official guidelines advise caution when this medicine is used in older adults, primarily due to the mechanism of action of the Cinitapride component. Additionally, if an older adult has severe liver impairment, a healthcare provider may need to monitor or adjust the dose.


Q: Does Buprex have any official restrictions on driving or operating machinery?

Yes. Official safety advice recommends exercising caution when driving or operating heavy machinery. This is because the medicine may cause side effects such as dizziness, drowsiness, or changes in vision, which could affect concentration and motor skills.


Q: What is the risk of Buprex causing a serious allergic reaction?

Serious allergic reactions are rare but recognized as a possible adverse effect associated with the components of this medicine. Regulatory information describes symptoms such as hives, swelling of the face, or difficulty breathing. Should these occur, these symptoms are noted as requiring immediate medical evaluation.


Q: Why do some people report feeling restless after taking Buprex?

Although restlessness is not listed as a common side effect, the Omeprazole component has been associated in rare post-marketing reports with nervous system effects. These effects may include agitation or tremors, which could contribute to a feeling of restlessness in some individuals.


Q: Does Buprex affect stomach bacteria or the gut microbiome?

Academic research suggests that the acid-reducing action of the Omeprazole component can lead to changes in the natural balance of the gut flora, sometimes reducing the diversity of the stomach bacteria. This effect is a documented topic of study regarding PPIs.


Q: Can Buprex cause dry mouth or changes in taste?

Yes, the components of Buprex have been associated with reports of dry mouth. Changes in the sense of taste, sometimes referred to as taste perversion, are also included in the reported side effects.


Q: Is it possible to take Buprex too often?

Yes, taking more than the prescribed dose is considered an overdose, as with any medication. Symptoms reported with overdose include blurred vision, confusion, drowsiness, or fast heartbeat. If excessive amounts are taken, medical assistance is required.


Q: What are the warning signs of a severe side effect from Buprex?

Official safety information advises monitoring for specific warning signs of severe effects. These include persistent, watery diarrhea (which may indicate a C. difficile infection), signs of low magnesium (like tremors or irregular heartbeat), or a new rash with fever that could signal a skin reaction.


Q: Are there any known issues with Buprex and high blood pressure medication?

Yes. Official interaction summaries note that the Cinitapride component may potentially decrease the effect of some high blood pressure medications (antihypertensives). Addressing the use of all existing medications with a healthcare provider is necessary to manage this potential interaction.


Q: Does taking Buprex affect the results of certain medical tests?

Regulatory information indicates that the Omeprazole component may interfere with the results of specific medical tests used to detect Neuroendocrine Tumors. Official information indicates that a healthcare provider may adjust the medicine schedule before these specific tests.


Q: Does the time of day I take Buprex matter?

Yes. The medication is typically recommended to be taken in the morning, which is the preferred time. Furthermore, it must be taken at least one hour before a meal, as instructed in the official administration protocols.


Q: Can Buprex cause mood changes or anxiety?

Yes. The Omeprazole component has been associated with psychiatric effects in rare post-marketing reports. These reported effects include mood changes, anxiety, agitation, and depression.


Q: What is the average length of time Buprex is prescribed for?

The total course of treatment is defined as short-term in regulatory documents. It is typically limited to a period between 4 and 8 weeks, as this duration is generally considered sufficient for the healing of conditions such as erosive esophagitis.


Q: Does Buprex have a risk of causing nutrient deficiencies, like Vitamin B12 or Magnesium?

Official safety warnings state that long-term, daily use of the Omeprazole component (typically exceeding one year) may be associated with reduced levels of magnesium in the body. Furthermore, a deficiency in Vitamin B12 has also been reported in some patients under these long-term conditions.

Advertisements

How should Buprex (Cinitapride,Omeprazole) be stored and disposed of?

How to Store and Dispose of Buprex (Cinitapride, Omeprazole)

Official regulatory documents define strict conditions for the storage and disposal of this medication to maintain its integrity and labeled shelf life.

Storage Requirements

The capsules must be stored at a temperature not exceeding 30°C (86°F). It is mandatory to protect the medicine from both light and moisture, requiring it to be kept in its original package. If supplied in a bottle, the container must remain tightly closed for protection. A critical safety requirement is that the product must be stored out of the sight and reach of children.

Disposal Instructions

Any unused or expired medicine must be disposed of in accordance with local requirements. For household disposal, if no drug take-back program is available, the medicine should be mixed with an undesirable substance, placed in a sealed container, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Buprex (Cinitapride,Omeprazole) found in:

A-Z Index: